Expression of purinergic P2X(7) receptor in rat brain during the symptomatic phase of experimental autoimmune encephalomyelitis and after recovery of neurological deficits

• Autorzy: Grygorowicz T. , Sulejczak D. , Struzynska L.
• Języki publikacji: EN

Abstrakty

EN

Purinergic ionotropic P2X7 receptor is widely distributed in brain. Strong evidence suggests that this receptor is related to inflammatory and neurodegenerative changes in many pathological states of central nervous system (CNS), including multiple sclerosis (MS). Experimental autoimmune encephalomyelitis (EAE) is the commonly used animal model of MS. In this study we investigate the expression of P2X7R protein in rat brain in the symptomatic phase of EAE (day 10 post immunization) and after reversion of neurological symptoms (day 20 p.i.). We found the increased level of P2X7R protein in brain homogenates of EAE rats in both examined time windows. Immunohistochemical study revealed enhanced receptor's immunoreactivity. Immunoblots done with isolated cellular brain fractions indicated that the P2X7R overexpression is related to synaptosomal fraction in the symptomatic phase and to the glial (GPV) fraction in the recovery phase of EAE. Concomitantly, we noticed overexpression of astroglial marker GFAP in brain homogenates and astroglial fraction (GPV), so as its enhanced immunoreactivity in brain sections (10 days p.i.) which did not decline to control values in the recovery phase, similarly to P2X7R expression. Results suggest the involvement of P2X7R-mediated signaling in the pathomechanisms of EAE with the possible relevance of astrocytic pool of cells.

• Wydawca: -
• Czasopismo: Acta Neurobiologiae Experimentalis
• Rocznik: 2011
• Tom: 71
• Numer: 1
• Opis fizyczny: p.65-73,fig.,ref.

Twórcy

autor

Grygorowicz T.

• Laboratory of Pathoneurochemistry, Mossakowski Medical Research Centre, Department of Neurochemistry, Polish Academy of Sciences, Warsaw, Poland

autor

Sulejczak D.

• Mossakowski Medical Research Centre, Department of Experimental Pharmacology, Polish Academy of Sciences, Warsaw, Poland

autor

Struzynska L.

• Laboratory of Pathoneurochemistry, Mossakowski Medical Research Centre, Department of Neurochemistry, Polish Academy of Sciences, Warsaw, Poland

Bibliografia

• Abbracchio MP, Burnstock G (1994) Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther 64: 445-475.
• Ayers MA, Hazelwood LJ, Catmull DV, Wang D, McKormack Q, Bernard CCA, Orian JM (2004) Early glial responses in murine models of multiple sclerosis. Neurochem Int 45: 409-419.
• Bannerman P, Hahn A, Soulika A, Gallo V, Pleasure D (2007) Astrogliosis in EAE spinal cord: derivation from radial glia, and relationships to oligodendroglia. Glia 55: 57-64.
• Białkowiec-Iskra E, Kurkowska-Jastrzębska I, Joniec I, Ciesielska A, Członkowska A, Członkowski A (2007) Dopamine, serotonin and noradrenaline changes in the striatum of C57BL mice following myelin oligodendrocyte glycoprotein (MOG) 35-55 and complete Freund adjuvant (CFA) administration. Acta Neurobiol Exp (Wars) 67: 379-388.
• Booth RFG, Clark JB (1978) A rapid method for the prepara­tion of relatively pure metabolically competent synaptosomes from rat brain. Biochem J 176: 365-370.
• Collo G, Neidhart S, Kawashima E, Kosco-Vilbois M, North RA, Buell G (1997) Tissue distribution of the P2X7 receptor. Neuropharmacol 36: 1277-1283.
• Compston A, Coles A (2000) Multiple sclerosis. Lancet 359: 1221-1231.
• Członkowska A (2009) Manipulating inflammation and gli­osis in neurological diseases - a clinical perspective. Acta Neurobiol Exp (Wars) 69: abstract SIV.2
• Daniels KK, Vickroy TW (1998) Simultaneous isolation of glial and neuronal fractions from rat brain homogenates: comparison of high-affinity L-glutamate transport prop­erties. Neurochem Res 23: 103-113.
• Di Virgilio F, Chiozzi P, Falzoni S Ferrari D, Sanz JM, Venketaraman V, Baricordi OR (1998) Cytolytic P2X purinoceptors. Cell Death Differ 5:191-199.
• Franke H, Krugel U, Illes P (2006) P2 receptors and neu­ronal injury. Eur J Physiol 452: 622-644.
• Hamilton N, Vayro S, Kirchhoff F, Verkhatsky A, Robbins J, Gorecki DC, Butt AM (2008) Mechanism of ATP- and glutamate-mediated calcium signaling in white matter asytocytes. Glia 56: 734-749.
• Holley JE, Gveric D, Newcombe J, Cuzner ML, Gutowski NJ (2003) Astrocyte characterization in the multiple scle­rosis scar. Neuropathol Appl Neurobiol 29: 434-444.
• Duan S, Anderson CM, Keung EC, Chen Y, Swanson RA (2003) P2X7 receptor-mediated release of excitatory amino acids from astrocytes. J Neurosci 23: 1320­1328.
• Kerschensteiner M, Stadelmann C, Buddeberg BS, Merkler D, Bareyre FM, Anthony DC, Linington C, Bruck W, Schwab ME (2004) Animal model -targeting experimen­tal autoimmune encephalomyelitis lesions to a predeter­mined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis. Am J Pathol 164: 1455-1469.
• Kim JE, Ryu HJ, Yeo SI, KangTC (2010) P2X7 receptor differentially modulates astroglial apoptosis and clasma- todendrosis in the rat brain following status epilepticus. Hippocampus. [Epub ahead of print]
• Kwiatkowska-Patzer B, Michalkiewicz J, Kubiszewska I, Zielińska J, Kasarello K, Kurzepa K, Lipkowski A (2009) Spinal cord hydrolysate ameliorates immunological reac­tions in experimental allergic encephalomyelitis. Acta Neurobiol Exp 69: 73-78.
• Le Feuvre RA, Brough D, Touzani O, Rothwell NJ (2003) Role of P2X7 receptors in ischemic and excitotoxic brain injury in vivo. J Cereb Blood Flow Metab 23: 381-384.
• Lister MF, Sharkey J, Sawatzky DA, Hodgkiss JP, Davidson DJ, Rossi AG, Finlayson K (2007) The role of the puriner- gic P2X7 receptor in inflammation. J Inflamm (Lond) 4: 5.
• Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
• Maglione M, Tress O, Haas B, Karram K, Trotter J, Willecke K, Kettenmann H. (2010) Oligodendrocytes in mouse corpus callosum are coupled via gap junction channels formed by connexin47 and connexin32. Glia 58: 1104­1117.
• Matute C, Torre I, Perez-Cerda F, Perez-Samartin A, Alberdi E, Etxebarria E, Arranz AM, Ravid R, Rodrigez- Antigüedad A, Sanchez-Gomez MV, Domercq M (2007) P2X7 receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoim­mune encephalomyelitis. J Neurosci 27: 9525-9533.
• McLarnon JG, Ryu JK, Walker DG, Choi HB (2006) Upregulatedexpression of purinergic P2X(7) receptor in Alzheimer disease and amyloid-beta peptide-treated microglia and in peptide injected rat hippocampus. J Neuropathol Exp Neurol 65: 1090-1097.
• Mingam R, De Smedt V, Amédée T, Bluthé RM, Kelley KW, Dantzer R, Layé S (2008) In vitro and in vivo evidence for a role of the P2X7 receptor in the release of IL-1ß in the murine brain. Brain Behav Immun 22: 234-244.
• Morelli A, Ferrari D, Bolognesi G, Rizzuto R, Di Virgilio F (2001) Proapoptotic plasma membrane pore: P2X7 recep­tor. Drug Dev Res 52: 571-578.
• Norton WT, Poduslo SE (1973) Myelination in rat brain: method of myelin isolation. J Neurochem 21: 749-757.
• Pham H, ramp AA, Klonis N, Ng SW, Klopstein A, Ayers MM, Orian M (2009) The astrocytic response in early experimental autoimmune encephalomyelitis occurs across both the grey and white matter compartments. J Neuroimmunol 208: 30-39.
• Pirko L, Lucchinetti CF, Subramainan S, Bakshi R (2007) Grey matter involvement in multiple sclerosis. Neurology 68: 634-642.
• Sharp AJ, Polak PE, Simonini V, Lin SX, Richardson JC, Bongarzone ER, Feinstein DL (2008) P2X7 deficiency suppresses development of experimental autoimmune encephalomyelitis. J Neuroinflamm 5: 33.
• Sim JA, Young MT, Sung HY, North RA, Surprenant A (2004) Reanalysis of P2X7 receptor expression in rodent brain. J Neurosci 24: 6307-6314.
• Sofroniew MV, Vinters HV (2010) Astrocytes: bilogy and pathology. Acta Neuropathol 110: 7-35.
• Struzynska L (2000) The protective role of astroglia in the early period of experimental lead toxicity in the rat. Acta Neurobiol Exp (Wars) 60: 167-173.
• Struzynska L, Bubko I, Walski M, Rafalowska U (2001) Astroglial reaction during the early phases of acute lead toxicity in the adult rat brain. Toxicol 165: 121-131.
• Suadicani SO, Brosnan CF, Scemes E (2006) P2X7 recep­tors mediate ATP release and amplification of astrocytic intercellular Ca2+ signaling. J Neurosci 26: 1378­1385.
• Surprenant A, Rassendren F, Kawashima E. North RA, Buell G (1996) The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor P2X7. Science 272: 735­738.
• Takenouchi T, Sekiyama K, Sekigawa A, Fujita M, Waragai M, Sugama S, Iwamaru H, Hashimoto M (2010) P2X7 receptor signaling pathway as a therapeutic target for neurodegen- erative diseases. Arch Immunol Ther Exp 58: 91-96.
• Tsumoda I, Fujinami RS (1996) Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J Neuropathol Exp Neurol 55: 673-686.
• Wang D, Ayers MM, Catmuli DV, Hazelwood LJ, Bernard CCA, Orian JM (2005) Astrocyte-associated axonal dam­age in pre-onset stages of experimental autoimmune encephalomyelitis. Glia 51: 235-240.
• Yanagisawa D, Kitamura Y, Takata K, Hide I, Nakata Y, Taniguchi T (2008) Possible involvement of P2X7 receptor activation in microglial neuroprotection against focal cere­bral ischemia in rats. Biol Pharm Bull 31: 1121-1130.